文献速递乳腺技术与安全US

常规超声联合临床病理特征预测乳腺癌新辅助治疗后腋窝状态:病例对照研究

Combined conventional ultrasonography with clinicopathological features to predict axillary status after neoadjuvant therapy for breast cancer: A case-control study.
PubMed 文献 · Br J Radiol · 2023-10-24

本研究回顾性纳入2019年6月至2022年3月接受新辅助系统治疗的329例淋巴结阳性乳腺癌患者,分析治疗前后乳腺病灶及腋窝淋巴结的超声与临床病理特征,构建联合模型预测腋窝病理完全缓解。联合模型AUC为0.882,优于临床病理模型(AUC 0.807)和超声特征模型(AUC 0.795)。

要点

  • 联合模型预测腋窝pCR的AUC为0.882,优于临床病理模型(0.807)和超声特征模型(0.795)。
  • 筛选出8个腋窝pCR独立预测因素,包括临床N分期、ERBB2状态、Ki-67及治疗后乳腺病灶最大径缩小率和边缘、淋巴结短径、皮质厚度和脂肪门。
  • 联合模型可在术前无创评估腋窝pCR,有助于更准确识别新辅助系统治疗后达到腋窝pCR的乳腺癌患者。

核心结论

  • 由超声和临床病理特征构建的联合模型预测腋窝pCR具有良好诊断效能,可更准确识别新辅助系统治疗后达到腋窝pCR的乳腺癌患者。

研究设计与样本

  • 回顾性病例对照研究,纳入329例淋巴结阳性并接受新辅助系统治疗的乳腺癌患者,分析治疗前后乳腺病灶及腋窝淋巴结的超声和临床病理特征,采用多变量逻辑回归和受试者工作特征曲线分析。

诊断标准与关键数值

  • 联合模型预测腋窝pCR的AUC为0.882,临床病理模型AUC为0.807,超声特征模型AUC为0.795;8个独立预测因素为临床N分期、ERBB2状态、Ki-67、治疗后乳腺病灶最大径缩小率、乳腺病灶边缘、淋巴结短径、淋巴结皮质厚度、淋巴结脂肪门。

临床应用与阅片要点

  • 联合模型可在术前无创评估腋窝pCR,帮助更准确识别新辅助系统治疗后达到腋窝pCR的乳腺癌患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to evaluate the value of a model combining conventional ultrasonography and clinicopathologic features for predicting axillary status after neoadjuvant therapy in breast cancer.

METHODS: This retrospective study included 329 patients with lymph node-positive who underwent neoadjuvant systemic treatment (NST) from June 2019 to March 2022. Ultrasound and clinicopathological characteristics of breast lesions and axillary lymph nodes were analyzed before and after NST. The diagnostic efficacy of ultrasound, clinicopathological characteristics, and combined model were evaluated using multivariate logistic regression and receiver operator characteristic curve (ROC) analyses.

RESULTS: The area under ROC (AUC) for the ability of the combined model to predict the axillary pathological complete response (pCR) after NST was 0.882, that diagnostic effectiveness was significantly better than that of the clinicopathological model (AUC of 0.807) and the ultrasound feature model (AUC of 0.795). In addition, eight features were screened as independent predictors of axillary pCR, including clinical N stage, ERBB2 status, Ki-67, and after NST the maximum diameter reduction rate and margins of breast lesions, the short diameter, cortical thickness, and fatty hilum of lymph nodes.

CONCLUSIONS: The combined model constructed from ultrasound and clinicopathological features for predicting axillary pCR has favorable diagnostic results, which allowed more accurate identification of BC patients who had received axillary pCR after NST.

ADVANCES IN KNOWLEDGE: A combined model incorporated ultrasound and clinicopathological characteristics of breast lesions and axillary lymph nodes demonstrated favorable performance in evaluating axillary pCR preoperatively and non-invasively.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Yan Y, Jiang T, Sui L, et al. Combined conventional ultrasonography with clinicopathological features to predict axillary status after neoadjuvant therapy for breast cancer: A case-control study. Br J Radiol. 2023. PMID: 37750854. doi:10.1259/bjr.20230370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。